Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antibodies, Neutralizing | 27 | 2021 | 25288 | 0.67 | Why? |
| Hepatitis E virus | 3 | 2019 | 306 | 0.43 | Why? |
| Antibodies, Monoclonal | 7 | 2021 | 8041 | 0.38 | Why? |
| Spike Glycoprotein, Coronavirus | 16 | 2021 | 37182 | 0.38 | Why? |
| Luminescent Measurements | 3 | 2017 | 924 | 0.34 | Why? |
| Antibodies, Viral | 17 | 2021 | 51949 | 0.34 | Why? |
| Neutralization Tests | 7 | 2021 | 6698 | 0.31 | Why? |
| HEK293 Cells | 11 | 2021 | 8394 | 0.29 | Why? |
| Mice | 18 | 2021 | 21357 | 0.27 | Why? |
| Hepatitis E | 2 | 2019 | 319 | 0.27 | Why? |
| Disease Models, Animal | 9 | 2021 | 10998 | 0.24 | Why? |
| Animals | 34 | 2021 | 78931 | 0.24 | Why? |
| Gene Knock-In Techniques | 2 | 2020 | 124 | 0.24 | Why? |
| Lens Plant | 1 | 2021 | 20 | 0.24 | Why? |
| Quinolizidines | 1 | 2021 | 14 | 0.23 | Why? |
| Alternaria | 1 | 2021 | 18 | 0.23 | Why? |
| Plant Lectins | 1 | 2021 | 114 | 0.21 | Why? |
| Genetic Techniques | 1 | 2020 | 79 | 0.21 | Why? |
| Mice, Inbred BALB C | 9 | 2021 | 5814 | 0.21 | Why? |
| Whole Body Imaging | 2 | 2017 | 116 | 0.21 | Why? |
| Ketones | 1 | 2021 | 150 | 0.20 | Why? |
| Viral Vaccines | 7 | 2020 | 7560 | 0.20 | Why? |
| Vaccines, DNA | 3 | 2021 | 871 | 0.20 | Why? |
| Vaccines, Inactivated | 3 | 2021 | 1562 | 0.19 | Why? |
| Mice, Inbred C57BL | 5 | 2020 | 5542 | 0.18 | Why? |
| Food Microbiology | 1 | 2019 | 114 | 0.18 | Why? |
| Cell Line | 7 | 2021 | 12040 | 0.18 | Why? |
| Viral Envelope Proteins | 3 | 2020 | 3539 | 0.17 | Why? |
| Nipah Virus | 1 | 2019 | 121 | 0.17 | Why? |
| Cathepsin L | 1 | 2021 | 566 | 0.17 | Why? |
| Marburg Virus Disease | 1 | 2017 | 41 | 0.17 | Why? |
| Mink | 1 | 2021 | 399 | 0.17 | Why? |
| Henipavirus Infections | 1 | 2019 | 122 | 0.17 | Why? |
| Human papillomavirus 16 | 1 | 2017 | 95 | 0.17 | Why? |
| Marburgvirus | 1 | 2017 | 71 | 0.16 | Why? |
| Polymers | 1 | 2021 | 507 | 0.16 | Why? |
| Genetic Vectors | 3 | 2021 | 1600 | 0.16 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.15 | Why? |
| Genetic Engineering | 1 | 2017 | 325 | 0.15 | Why? |
| Virus Physiological Phenomena | 1 | 2017 | 155 | 0.15 | Why? |
| Receptors, Virus | 3 | 2021 | 5659 | 0.15 | Why? |
| Adenoviruses, Human | 1 | 2017 | 195 | 0.15 | Why? |
| Adenoviridae | 1 | 2021 | 1151 | 0.15 | Why? |
| Virus Internalization | 4 | 2021 | 7921 | 0.15 | Why? |
| HIV Seropositivity | 1 | 2017 | 320 | 0.14 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2017 | 349 | 0.14 | Why? |
| Piperidines | 1 | 2021 | 795 | 0.14 | Why? |
| Amino Acid Substitution | 2 | 2019 | 1706 | 0.14 | Why? |
| Capsid Proteins | 1 | 2017 | 365 | 0.14 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 511 | 0.14 | Why? |
| Infertility, Male | 1 | 2019 | 322 | 0.14 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.13 | Why? |
| Cysteine Proteinase Inhibitors | 1 | 2021 | 675 | 0.13 | Why? |
| Influenza A Virus, H7N9 Subtype | 1 | 2019 | 415 | 0.13 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.13 | Why? |
| Vero Cells | 8 | 2021 | 14117 | 0.13 | Why? |
| Binding Sites | 6 | 2021 | 6201 | 0.13 | Why? |
| Macaca mulatta | 5 | 2021 | 3716 | 0.13 | Why? |
| Chikungunya Fever | 1 | 2017 | 345 | 0.13 | Why? |
| Injections, Intramuscular | 3 | 2021 | 800 | 0.12 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.12 | Why? |
| Madin Darby Canine Kidney Cells | 3 | 2020 | 640 | 0.12 | Why? |
| Guinea Pigs | 3 | 2019 | 420 | 0.12 | Why? |
| AIDS Vaccines | 1 | 2017 | 452 | 0.12 | Why? |
| Antibody Specificity | 1 | 2017 | 1328 | 0.12 | Why? |
| HeLa Cells | 3 | 2021 | 1303 | 0.12 | Why? |
| Dogs | 4 | 2021 | 2529 | 0.12 | Why? |
| Mutation | 6 | 2021 | 12376 | 0.11 | Why? |
| HIV Antibodies | 1 | 2017 | 776 | 0.11 | Why? |
| Drug Carriers | 1 | 2017 | 590 | 0.11 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2018 | 1061 | 0.11 | Why? |
| Antiviral Agents | 5 | 2021 | 41703 | 0.11 | Why? |
| Protein Domains | 5 | 2021 | 6563 | 0.11 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.11 | Why? |
| Immunization, Passive | 3 | 2021 | 10067 | 0.10 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.10 | Why? |
| Plant Extracts | 1 | 2021 | 1514 | 0.10 | Why? |
| Genetic Variation | 2 | 2021 | 3919 | 0.10 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.10 | Why? |
| Swine Diseases | 1 | 2019 | 1219 | 0.09 | Why? |
| Epitopes | 4 | 2021 | 4113 | 0.09 | Why? |
| Adaptive Immunity | 1 | 2020 | 2585 | 0.09 | Why? |
| Luciferases, Firefly | 2 | 2017 | 20 | 0.09 | Why? |
| Peptidyl-Dipeptidase A | 4 | 2020 | 9659 | 0.08 | Why? |
| Staining and Labeling | 2 | 2017 | 169 | 0.08 | Why? |
| Rabbits | 2 | 2021 | 1171 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Macaca fascicularis | 2 | 2021 | 1009 | 0.08 | Why? |
| T-Lymphocytes | 2 | 2020 | 6670 | 0.08 | Why? |
| Molecular Structure | 2 | 2021 | 1539 | 0.08 | Why? |
| Swine | 3 | 2020 | 3352 | 0.08 | Why? |
| RNA, Messenger | 1 | 2020 | 5131 | 0.08 | Why? |
| Genes, Reporter | 2 | 2017 | 472 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.07 | Why? |
| Models, Molecular | 4 | 2021 | 7616 | 0.07 | Why? |
| Humans | 37 | 2021 | 930598 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Cattle | 2 | 2020 | 1336 | 0.07 | Why? |
| Protein Binding | 4 | 2021 | 11430 | 0.07 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.07 | Why? |
| Virus Attachment | 2 | 2021 | 1259 | 0.06 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.06 | Why? |
| Crystallography, X-Ray | 2 | 2021 | 2689 | 0.06 | Why? |
| Cryoelectron Microscopy | 2 | 2021 | 2372 | 0.06 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.06 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.06 | Why? |
| Limit of Detection | 2 | 2020 | 2698 | 0.06 | Why? |
| Pan troglodytes | 1 | 2021 | 157 | 0.06 | Why? |
| Seeds | 1 | 2021 | 114 | 0.06 | Why? |
| Cathepsin B | 1 | 2021 | 101 | 0.05 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
| Haplorhini | 1 | 2021 | 307 | 0.05 | Why? |
| Receptors, CXCR3 | 1 | 2020 | 159 | 0.05 | Why? |
| Female | 18 | 2021 | 380317 | 0.05 | Why? |
| Immunogenicity, Vaccine | 3 | 2021 | 4624 | 0.05 | Why? |
| Tropism | 1 | 2021 | 210 | 0.05 | Why? |
| Mice, Inbred ICR | 1 | 2020 | 242 | 0.05 | Why? |
| RNA, Viral | 4 | 2020 | 32276 | 0.05 | Why? |
| Binding, Competitive | 1 | 2020 | 264 | 0.05 | Why? |
| RAW 264.7 Cells | 1 | 2020 | 316 | 0.05 | Why? |
| Stomach | 1 | 2020 | 141 | 0.05 | Why? |
| Double-Blind Method | 2 | 2021 | 5988 | 0.05 | Why? |
| Crystallization | 1 | 2020 | 331 | 0.05 | Why? |
| Protein Structure, Quaternary | 1 | 2020 | 455 | 0.05 | Why? |
| Abattoirs | 1 | 2019 | 94 | 0.05 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2021 | 424 | 0.05 | Why? |
| Vaccine Potency | 1 | 2020 | 339 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2020 | 616 | 0.05 | Why? |
| Serum | 1 | 2020 | 294 | 0.05 | Why? |
| Endonucleases | 1 | 2018 | 68 | 0.05 | Why? |
| Blotting, Western | 1 | 2021 | 863 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Microscopy, Electron | 1 | 2021 | 830 | 0.04 | Why? |
| Vesicular stomatitis Indiana virus | 1 | 2020 | 354 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2021 | 987 | 0.04 | Why? |
| Blood | 1 | 2019 | 274 | 0.04 | Why? |
| Mutagenesis, Site-Directed | 1 | 2019 | 449 | 0.04 | Why? |
| Molecular Dynamics Simulation | 2 | 2021 | 4155 | 0.04 | Why? |
| Milk | 1 | 2018 | 158 | 0.04 | Why? |
| Plasmids | 1 | 2020 | 840 | 0.04 | Why? |
| Models, Animal | 1 | 2020 | 788 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2021 | 1132 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.04 | Why? |
| Lassa virus | 1 | 2017 | 99 | 0.04 | Why? |
| Farms | 1 | 2018 | 269 | 0.04 | Why? |
| Reference Standards | 1 | 2021 | 1163 | 0.04 | Why? |
| Receptors, IgG | 1 | 2020 | 578 | 0.04 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.04 | Why? |
| Virus Activation | 1 | 2021 | 480 | 0.04 | Why? |
| Neuraminidase | 1 | 2019 | 289 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2020 | 1027 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2018 | 8843 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Spleen | 1 | 2020 | 877 | 0.04 | Why? |
| Glycosylation | 1 | 2020 | 1255 | 0.04 | Why? |
| Male | 12 | 2021 | 367725 | 0.04 | Why? |
| China | 5 | 2021 | 50654 | 0.04 | Why? |
| Epitope Mapping | 1 | 2020 | 1240 | 0.04 | Why? |
| Trachea | 1 | 2020 | 894 | 0.04 | Why? |
| Chemokine CCL2 | 1 | 2017 | 389 | 0.04 | Why? |
| Vaccines, Subunit | 1 | 2021 | 1088 | 0.04 | Why? |
| Biological Assay | 1 | 2017 | 367 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.03 | Why? |
| Virus Assembly | 1 | 2017 | 438 | 0.03 | Why? |
| Protein Multimerization | 1 | 2020 | 1336 | 0.03 | Why? |
| A549 Cells | 1 | 2020 | 2066 | 0.03 | Why? |
| Th1 Cells | 1 | 2020 | 1228 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.03 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 624 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Semen | 1 | 2019 | 550 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2021 | 2275 | 0.03 | Why? |
| Immunization Schedule | 1 | 2020 | 1305 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2017 | 1115 | 0.03 | Why? |
| Virulence | 1 | 2020 | 2172 | 0.03 | Why? |
| Virology | 1 | 2017 | 489 | 0.03 | Why? |
| Containment of Biohazards | 1 | 2019 | 762 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2021 | 2886 | 0.03 | Why? |
| Papillomavirus Vaccines | 1 | 2017 | 405 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.03 | Why? |
| Membrane Glycoproteins | 1 | 2020 | 2273 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2018 | 1265 | 0.03 | Why? |
| Orthomyxoviridae Infections | 1 | 2019 | 1001 | 0.03 | Why? |
| CRISPR-Cas Systems | 1 | 2020 | 1397 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Immunization | 1 | 2019 | 2019 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.02 | Why? |
| Papillomavirus Infections | 1 | 2017 | 861 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Nanoparticles | 1 | 2020 | 2040 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Lung | 3 | 2020 | 31049 | 0.02 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.02 | Why? |
| Protein Conformation | 1 | 2017 | 4386 | 0.02 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Feces | 1 | 2018 | 4235 | 0.02 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.02 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.02 | Why? |
| Liver | 1 | 2019 | 4007 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Aging | 1 | 2020 | 3581 | 0.02 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.02 | Why? |
| Brain | 1 | 2020 | 5133 | 0.02 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.01 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Phylogeny | 1 | 2019 | 13341 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 11367 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |